WONDER DRUG CLOBBERS DIABETES!
Globe US|January 02, 2023
Patients with type 1 diabetes can take a single 14-day course of infusions to delay the disease's late stage
WONDER DRUG CLOBBERS DIABETES!

A BREAKTHROUGH drug recently approved by the FDA targets the root cause of type 1 diabetes (T1D) — and the first-of-its-kind treatment may delay the disease’s damaging late stage by two years or more!

 Teplizumab, an immunotherapy infusion, was given the green light for patients aged eight and above. It is intended for individuals who are in the early phases of the autoimmune condition, which ultimately leaves the body unable to control blood sugar levels.

Esta historia es de la edición January 02, 2023 de Globe US.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición January 02, 2023 de Globe US.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.